This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The European Medicines Agency (EMA) is closed from 18:00 on Wednesday 28 May 202...
EMA’s human medicines committee (CHMP) has recommended several changes to the wa...
EMA’s human medicines committee (CHMP) has started a review of medicines contain...
EMA has recommended granting a conditional marketing authorisation in the Europe...
Ten new medicines recommended for approvalEMA’s human medicines committee (CHMP)...
Review of medicines containing finasteride and dutasteride concluded Finasteride...
Following an EU-wide review of available data on finasteride and dutasteride med...
EMA and the Heads of Medicines Agencies (HMA) have published a joint workplan "D...
EMA’s safety committee (PRAC) has started a review of Ixchiq (a live attenuated ...
The European Medicines Agency's (EMA) office is closed from 18:00 on Thursday 8 ...
The Committee re-elected Johan Schefferlie from the Netherlands as its Chair for...
EMA’s Emergency Task Force (ETF) has recommended updating COVID-19 vaccines to t...
EMA has recommended granting a conditional marketing authorisation in the Europe...
EMA's office is closed from 18:00 on Wednesday 16 April 2025 to 08:30 on Tuesday...
EMA and the Heads of Medicines Agencies (HMA), through the Executive Steering Gr...
EMA’s Management Board has unanimously recommended the renewal of its Executive ...
16 new medicines recommended for approvalEMA’s human medicines committee (CHMP) ...
The European Medicines Agency's (EMA) office is closed from 18:00 on Wednesday 3...